EyePoint Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
Latest Filings
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
EyePoint Pharmaceuticals, Inc.
CIK #0001314102
EDGAR Form CIK 2011 - 2024
10-K [0001314102]
10-Q [0001314102]
3 [0001314102]
4 [0001314102]
5 [0001314102]
8-K [0001314102]
D [0001314102]
SC 13D [0001314102]
SC 13G [0001314102]
Form 13D/13G Filer Form 13D/13G Subject Filed
Adage Capital Management LP Eyepoint Pharmaceuticals Inc [2024-04-30]
Price T Rowe Associates Inc /MD/ Eyepoint Pharmaceuticals Inc [2024-02-14]
Franklin Resources Inc Eyepoint Pharmaceuticals Inc [2022-02-03]
RA Capital Management LP Eyepoint Pharmaceuticals Inc [2021-08-13]
Suvretta Capital Management LLC Eyepoint Pharmaceuticals Inc [2021-07-26]
Adage Capital Partners GP LLC Eyepoint Pharmaceuticals Inc [2021-02-12]
Ocumension Therapeutics Eyepoint Pharmaceuticals Inc [2021-01-22]
Franklin Resources Inc Eyepoint Pharmaceuticals Inc [2020-11-10]
EW Healthcare Partners LP Eyepoint Pharmaceuticals Inc [2018-04-10]
Rosalind Advisors Inc Psivida Corp [2017-04-07]
View All
Form 3/4/5 Subject 2011 - 2024
Hassan Fred
EyePoint Pharmaceuticals, Inc.
ANDO Goran
Zaderej Karen L.
Dicicco Wendy F
Lurker Nancy
Guyer David R
Duker Jay S.
Adamis Anthony P
Elston George
View All
Terms | Privacy | Guide
tony@aum13f.com